Skip to search formSkip to main contentSkip to account menu

ferroquine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND Cambodia is the epicentre of resistance emergence for virtually all antimalarial drugs. Selection and spread of… 
2013
2013
Hepatitis C virus (HCV) is a major cause of chronic liver disease. Despite recent success in improving anti‐HCV therapy… 
Highly Cited
2012
Highly Cited
2012
ABSTRACT Ferroquine (SSR97193), a ferrocene-quinoline conjugate, is a promising novel antimalarial currently undergoing clinical… 
Highly Cited
2011
Highly Cited
2011
BackgroundThe development and spread of drug resistant Plasmodium falciparum strains is a major concern and novel anti-malarial… 
2011
2011
Ferroquine (FQ), a chloroquine (CQ) analog, is being developed to treat persons with Plasmodium falciparum malaria. In 146 P… 
2010
2010
ABSTRACT The novel organometallic chloroquine analog ferroquine (SSR 97193) is effective against chloroquine-resistant… 
2010
2010
A malaria e uma doenca parasitaria que aflige aproximadamente 500 milhoes de pessoas e causa mais de um milhao de mortes por ano… 
2006
2006
Ferroquine (SSR97193) has been shown to be a promising antimalarial, both on laboratory clones and on field isolates. So far, no… 
Highly Cited
2002
Highly Cited
2002
Ferroquine (FQ) is a new antimalarial agent with a high blood schizotoncidal activity. Previous studies on this compound were…